Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M71,370Revenue $M6,494Net Margin (%)22.3Z-Score7.1
Enterprise Value $M71,352EPS $1.7Operating Margin %27.9F-Score6
P/E(ttm))56.8Cash Flow Per Share $4.4Pre-tax Margin (%)25.7Higher ROA y-yN
Price/Book15.910-y EBITDA Growth Rate %0Quick Ratio2.7Cash flow > EarningsY
Price/Sales11.35-y EBITDA Growth Rate %22.2Current Ratio2.9Lower Leverage y-yN
Price/Cash Flow17.9y-y EBITDA Growth Rate %1.7ROA % (ttm)10.8Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)25.9Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M801ROI % (ttm)17.8Gross Margin Increase y-yY

Gurus Latest Trades with CELG

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CELGRay Dalio 2014-03-31 Add0.07%$69.65 - $85.97
($79.51)
$ 89.1212%Add 962.69%142,400
CELGJohn Burbank 2014-03-31 Buy 0.01%$69.65 - $85.97
($79.51)
$ 89.1212%New holding, 1670 sh.3,340
CELGJohn Keeley 2014-03-31 Sold Out $69.65 - $85.97
($79.51)
$ 89.1212%Sold Out0
CELGRonald Muhlenkamp 2013-12-31 Add0.12%$72.25 - $85.39
($79.05)
$ 89.1213%Add 2.87%294,850
CELGRay Dalio 2013-12-31 Buy 0.01%$72.25 - $85.39
($79.05)
$ 89.1213%New holding, 6700 sh.13,400
CELGJohn Keeley 2013-09-30 Buy $60.13 - $77.31
($70.14)
$ 89.1227%New holding, 1320 sh.2,640
CELGMario Gabelli 2013-09-30 Add$60.13 - $77.31
($70.14)
$ 89.1227%Add 29.5%20,940
CELGJohn Hussman 2013-09-30 Sold Out -0.31%$60.13 - $77.31
($70.14)
$ 89.1227%Sold Out0
CELGRonald Muhlenkamp 2013-06-30 Reduce-0.96%$56.1 - $65.09
($60.18)
$ 89.1248%Reduce -21.92%285,770
CELGJoel Greenblatt 2013-06-30 Sold Out -0.01%$56.1 - $65.09
($60.18)
$ 89.1248%Sold Out0
CELGJohn Hussman 2013-03-31 Reduce-0.71%$39.24 - $57.96
($50.79)
$ 89.1276%Reduce -85.25%118,000
CELGJoel Greenblatt 2013-03-31 Reduce-0.17%$39.24 - $57.96
($50.79)
$ 89.1276%Reduce -94.2%4,660
CELGRay Dalio 2013-03-31 Sold Out -0.07%$39.24 - $57.96
($50.79)
$ 89.1276%Sold Out0
CELGJoel Greenblatt 2012-12-31 Add0.16%$35.65 - $41.04
($38.7)
$ 89.12130%Add 989.15%80,314
CELGMario Gabelli 2012-12-31 Add$35.65 - $41.04
($38.7)
$ 89.12130%Add 68.37%17,510
CELGRay Dalio 2012-12-31 Reduce-0.09%$35.65 - $41.04
($38.7)
$ 89.12130%Reduce -52.42%169,762
CELGRonald Muhlenkamp 2012-09-30 Buy 3%$31.48 - $38.64
($35.11)
$ 89.12154%New holding, 183415 sh.366,830
CELGJohn Hussman 2012-09-30 Buy 0.92%$31.48 - $38.64
($35.11)
$ 89.12154%New holding, 500000 sh.1,000,000
CELGRay Dalio 2012-09-30 Add0.03%$31.48 - $38.64
($35.11)
$ 89.12154%Add 23.04%356,762
CELGJoel Greenblatt 2012-09-30 Reduce-0.09%$31.48 - $38.64
($35.11)
$ 89.12154%Reduce -83.94%7,374
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CELG is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
CELG John Burbank 2014-03-313,34000.01New Buy
CELG Ray Dalio 2014-03-31142,4000.020.08+962.69%
CELG Ronald Muhlenkamp 2014-03-31298,6500.043.7+1.29%
CELG Mario Gabelli 2014-03-3121,54000.01-3.58%
CELG John Keeley 2014-03-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


CELG: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Celgene International Inc10% Owner 2014-07-08Buy200,000$10767.1view
KAPLAN GILLADirector 2014-06-09Sell30,000$80.817.3view
CELGENE CORP /DE/10% Owner 2014-05-05Buy1,100,000$42.86102.31view
KARSEN PERRY Asee remarks 2014-05-01Sell23,844$73.3918.15view
Celgene European Investment Co10% Owner 2014-04-29Buy294,800$4497.07view
CELGENE CORP /DE/10% Owner 2014-04-14Buy714,286$71138.71view
CASEY MICHAEL DDirector 2014-03-04Sell25,540$81.176.83view
KARSEN PERRY Asee remarks 2014-03-03Sell4,816$79.539.03view
CASEY MICHAEL DDirector 2014-02-28Sell4,460$82.145.56view
Celgene European Investment Co10% Owner 2014-02-10Buy340,000$29.25196.44view

Press Releases about CELG :

    Quarterly/Annual Reports about CELG:

    News about CELG:

    Articles On GuruFocus.com
    Ken Fisher's Top Increases of the First Quarter Apr 22 2014 
    David Winters' 2013 Letter to Wintergreen Fund Shareholders Mar 05 2014 
    You Can No Longer Ignore Biotech Feb 07 2014 
    Trying to Beat the Market Is a Fool’s Errand Oct 17 2013 
    Insiders Are Buying Idera Pharmaceuticals Sep 19 2013 
    comment on CELG Mar 20 2013 
    Growth Stocks: There Is a Lot of Value in this Market Part 2 Sep 27 2012 
    High frowth cheap in Jun 30 2012 
    52-Week High Companies: CVS, TSM, PM, ROST, CELG Feb 27 2012 
    52-Week High Companies: CELG, MON, ECL, SBUX, NWSA Jan 16 2012 


    More From Other Websites
    Celgene (CELG) Set to Beat Earnings Estimates on Strong Revs Jul 22 2014
    Alexion, 3 Other Top Biotechs Reporting Earnings Jul 22 2014
    Biogen Shares Rebound As Street Has A Change Of Heart Jul 21 2014
    Yellen Fire In The Biotech Theater Jul 17 2014
    Facebook, Twitter slip following cautious valuation comments from Fed Jul 15 2014
    Biotech Better Beat Earnings…Or Else Jul 14 2014
    Stocks Close Higher As Biotech, Internet Stocks Gain Jul 11 2014
    Celgene's Otezla Disappoints in Ankylosing Spondylitis Study Jul 10 2014
    Regeneron Picked a Heck of a Day to Announce Good News Jul 10 2014
    Celgene's Otezla fails trial Jul 09 2014
    Celgene's arthritis drug fails a test, but company's stock rises anyway Jul 09 2014
    Two Analysts Don't See Celgene's Weak Trial Results As A Huge Setback Jul 09 2014
    [video] Momentum buys Jul 09 2014
    Celgene shares higher despite missing primary endpoint in Otezla trial Jul 09 2014
    Celgene Drug Otezla Fails Trial, But Street Sanguine Jul 09 2014
    Celgene: Does Failed Trial Matter? Jul 09 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide